inflammatory diseases companies
Companies whose enriched business profile is tagged “inflammatory diseases”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.
- Roivant Sciences (ROIV) Health Care — Roivant Sciences is a biopharma company that accelerates drug development through a decentralized model of nimble, independent 'Vant' subsidiaries and proprietary computational tools. ask →
- Incyte (INCY) Health Care — Incyte is a biopharmaceutical company focused on discovering and developing innovative medicines for oncology and inflammatory conditions. ask →
- APOGEE THERAPEUTICS INC (APGE) Health Care — Apogee Therapeutics is a clinical-stage biotechnology firm developing advanced biologic therapies for inflammatory and immunology diseases, currently pending acquisition by AbbVie. ask →
- DIANTHUS THERAPEUTICS INC (DNTH) Health Care — Dianthus Therapeutics is a clinical-stage biopharmaceutical company developing targeted complement-pathway inhibitors to treat severe autoimmune and inflammatory diseases. ask →
- KINIKSA PHARMACEUTICALS INTERNATIO (KNSA) Health Care — Kiniksa is a biopharmaceutical company developing and commercializing therapies for chronic inflammatory and autoimmune diseases, with a pipeline featuring novel treatments for recurrent pericarditis. ask →
- ARCUS BIOSCIENCES INC (RCUS) Health Care — A clinical-stage biotech developing first-in-class and best-in-class small molecules and antibodies for cancer immunotherapy, with lead HIF-2α inhibitor in late-stage trials. ask →
- CELLDEX THERAPEUTICS INC (CLDX) Health Care — A clinical-stage biopharmaceutical company developing mast cell-targeted monoclonal and bispecific antibodies for chronic urticaria, inflammatory skin diseases, and systemic inflammatory conditions. ask →
- Cue Biopharma, Inc. (CUE) Health Care — Cue Biopharma engineers injectable biologics that selectively modulate disease-specific T cells to restore immune tolerance in autoimmune diseases and activate anti-tumor immunity in cancer. ask →
Not quite it? Describe exactly what you want →
Frequently asked
What are the largest inflammatory diseases companies?
By market capitalization, the largest inflammatory diseases companies in the catalog include Roivant Sciences (ROIV), Incyte (INCY), APOGEE THERAPEUTICS INC (APGE), DIANTHUS THERAPEUTICS INC (DNTH), KINIKSA PHARMACEUTICALS INTERNATIO (KNSA).
How many inflammatory diseases companies does stocks-llm track?
stocks-llm currently lists 8 inflammatory diseases companies (as of 2026-08-11), each with dated fundamentals from SEC EDGAR and market data. Informational only — not financial advice.
Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.
Last updated 2026-08-11.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.